ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 132313 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 132313; 2) Community: the network communities that were significantly associated with the response to NSC 132313; 3) Molecule: the relationships between components within communities and NSC 132313; 4) MDR: the compounds that were significantly associated with the NSC 132313.

NSC Compound Enrichment Correlation
NSC 53327 Null 0.0209467683758286 0.38424523
NSC 610459 Camptothecin Derivative 0.0209467683758286 0.85280197
NSC 623176 Null 0.0209467683758286 0.33884761
NSC 627168 2-[(3-N',N'-Dimethylamino)propyl]-9-methoxy-5-nitro-[6H]- pyrazolo[3,4,5-kl]acridine, free base 0.0209467683758286 0.24013146
NSC 628939 Null 0.0209467683758286 0.24358823
NSC 676395 Cyclobutanemethanol, 1-[[(2-amino-4-chloro-5-[(4-chlorophenyl)azo]- 6-pyrimidinyl)amino]methyl]-3-(3-phenylmethoxy)- 0.0209467683758286 0.30717571
NSC 681635 Camptothecin Derivative 0.0209467683758286 0.72531728
NSC 681639 Camptothecin Derivative 0.0209467683758286 0.81825227
NSC 682400 (-)7,8-Dihydrocalanolide A 0.0209467683758286 0.042292723
NSC 683922 Null 0.0209467683758286 0.045266986
Total:90  Current:46    [First] [Prev] [Next] [Last]